Pharma-Bio Serv (OTCMKTS:PBSV) was upgraded by ValuEngine from a “strong sell” rating to a “sell” rating in a report issued on Friday.

Shares of Pharma-Bio Serv (OTCMKTS:PBSV) remained flat at $$0.52 during trading on Friday. The company’s stock had a trading volume of 25,000 shares, compared to its average volume of 9,533. Pharma-Bio Serv has a 52-week low of $0.32 and a 52-week high of $0.99.

ILLEGAL ACTIVITY NOTICE: “Pharma-Bio Serv (PBSV) Upgraded at ValuEngine” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/02/pharma-bio-serv-pbsv-upgraded-at-valuengine.html.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab).

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Pharma-Bio Serv Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv Inc. and related companies with MarketBeat.com's FREE daily email newsletter.